| Name | Title | Contact Details |
|---|
The Michaels Organization is a privately-held family of companies dedicated to excellence in affordable, mixed-income, student, and military housing. Our business is serving families by building residential communities that stand the test of time and t...
Decision Resources, a Decision Resources Group company, is privately owned and offers a rich array of research publications, consulting and advisory services. For over three decades, Decision Resources has provided best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed, knowledgeable decisions. With over 200 employees worldwide, analysts at Decision Resources provide the pharmaceutical, biotech and financial services industries with the analytics they need to compete and thrive in an increasingly competitive marketplace. With access to almost 10,000 thought leaders, specialists, HMO formulary directors and general practitioners, our highly-credentialed analysts are able to reconcile real-world practice with hard numbers from the industry's most respected data sources.
Certes Financial Pros is a Minneapolis, MN-based company in the Business Services sector.
Cronos Consulting Group is a Etobicoke, ON-based company in the Business Services sector.
CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator) is a global non-profit partnership dedicated to accelerating early development antibacterial R&D to address the rising global threat of drug-resistant bacteria. CARB-X is led by Boston University and its funding is provided by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services; the Wellcome Trust, a global charity based in the UK; Germanys Federal Ministry of Education and Research (BMBF); the UK Department of Health and Social Cares Global Antimicrobial Resistance Innovation Fund (UK GAMRIF); the Bill & Melinda Gates Foundation, and with in-kind support from National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH) within the HHS. CARB-X is investing more than $500 million from 2016-2021 to support innovative antibiotics and other therapeutics, vaccines and rapid diagnostics. CARB-X supports the worlds largest and most innovative pipeline of preclinical products against drug-resistant infections. CARB-X focuses exclusively on high priority drug-resistant bacteria, especially Gram-negatives. CARB-X is headquartered at Boston University School of Law.